TransMedics Group, Inc.
TMDX
$133.81
-$8.12-5.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 476.83% | 186.26% | 110.56% | 70.11% | 116.58% |
| Total Depreciation and Amortization | 16.84% | 46.36% | 42.65% | 57.56% | 173.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.21% | 11.87% | 19.16% | 108.09% | -72.94% |
| Change in Net Operating Assets | 348.30% | 22,603.39% | -58.03% | -4.91% | 27.60% |
| Cash from Operations | 914.63% | 256.21% | 16.89% | 136.79% | 199.84% |
| Capital Expenditure | 84.18% | 61.81% | 38.79% | 67.46% | 55.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 102.96% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 84.04% | 61.81% | 38.79% | 67.46% | 68.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -51.93% | -33.38% | -4.93% | 28.35% | 416.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -53.69% | -33.38% | -4.93% | 28.35% | 416.22% |
| Foreign Exchange rate Adjustments | -97.67% | 1,404.84% | 306.94% | -335.27% | 318.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 300.87% | 621.49% | 40.56% | 120.30% | 78.98% |